Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort:
Hottest Latest Alphabetical (A-Z) Alphabetical (Z-A)
Type:
All Topic Review Biography
Topic Review
ABCDE Model of Sarcoidosis Care
The importance of comprehensive care in sarcoidosis is generally acknowledged [12,13]. Here, we describe the ABCDE model, that can be used to structure comprehensive sarcoidosis management in order to improve quality of life and outcomes for patients (Figure 1). This model includes the following components: the Assessment of symptoms and patient’s needs, Backing patients by providing support and education, treatment of Complaints and Comorbidities, Disease-modifying treatment, and the involvement of Extrapulmonary specialists. As disease activity, organ involvement, and patients’ preferences may vary during the disease course, regular reassessment is essential. The ABCDE model can provide guidance to clinicians during the first work-up and follow-up of patients with sarcoidosis.
  • 1.7K
  • 23 Oct 2020
Topic Review
ABCG2
The ABCG2 (also named breast cancer resistance protein—BCRP, or mitoxantrone resistance protein—MXR) is an integral membrane protein belonging to the ABC (ATP-binding cassette) protein superfamily. ABCG2 is an active transporter utilizing the energy of ATP binding and hydrolysis to translocate various substrate molecules across the plasma membrane from the cells to the extracellular space. Its transported substrates include endobiotics (endogenous substances), such as uric acid, as well as xenobiotics, such as anti-cancer drugs. ABCG2 plays a pivotal role in uric acid clearance; thus, its malfunction may lead to hyperuricemia and gout. On the other hand, ABCG2 residing in various barrier tissues is involved in the innate defense mechanisms of the body, influencing the absorption, distribution, excretion of potentially toxic endo- and exogenous compounds.
  • 615
  • 11 May 2021
Topic Review
ABCG2 Gene
ATP binding cassette subfamily G member 2 (Junior blood group)
  • 490
  • 24 Dec 2020
Topic Review
ABCG5 Gene
ATP binding cassette subfamily G member 5
  • 395
  • 24 Dec 2020
Topic Review
Abdominal Aortic Aneurysm
Abdominal aortic aneurysm (AAA) is a lethal degenerative vascular disease that affects, mostly, the elder population, with a high mortality rate (>80%) upon rupture. It features a dilation of the aortic diameter to larger than 30 mm or more than 50%. Diverse pathological processes are involved in the development of AAA, including aortic wall inflammation, elastin breakdown, oxidative stress, smooth muscle cell (SMC) phenotypic switching and dysfunction, and extracellular matrix degradation. 
  • 740
  • 21 Feb 2022
Topic Review
Abdominal Aortic Aneurysm Growth's Prediction
Abdominal aortic aneurysm represents a distinct group of vascular lesions, in terms of surveillance and treatment. Amongst clinically applicable biomarkers, D-dimers, LDL-C, HDL-C, TC, ApoB, and HbA1c were found to bear the most significant association with AAA growth rates. In terms of the experimental biomarkers, PIIINP, osteopontin, tPA, osteopontin, haptoglobin polymorphisms, insulin-like growth factor I, thioredoxin, neutrophil extracellular traps (NETs), and genetic factors, as polymorphisms and microRNAs were positively correlated with increased AAA expansion rates.
  • 469
  • 15 Jun 2021
Topic Review
Abdominal Wall Defect
An abdominal wall defect is an opening in the abdomen through which various abdominal organs can protrude. This opening varies in size and can usually be diagnosed early in fetal development, typically between the tenth and fourteenth weeks of pregnancy. There are two main types of abdominal wall defects: omphalocele and gastroschisis. Omphalocele is an opening in the center of the abdominal wall where the umbilical cord meets the abdomen. Organs (typically the intestines, stomach, and liver) protrude through the opening into the umbilical cord and are covered by the same protective membrane that covers the umbilical cord. Gastroschisis is a defect in the abdominal wall, usually to the right of the umbilical cord, through which the large and small intestines protrude (although other organs may sometimes bulge out). There is no membrane covering the exposed organs in gastroschisis.
  • 385
  • 04 Feb 2021
Topic Review
Aberrant MET Receptor Tyrosine Kinase Signaling in Glioblastoma
Despite therapeutic advances, the treatment of brain tumors, including glioblastoma (GBM), an aggressive primary brain tumor associated with poor prognosis and resistance to therapy, remains a significant challenge. Receptor tyrosine kinases (RTKs) are critical during development and in adulthood. Dysregulation of RTKs through activating mutations and gene amplification contributes to many human cancers and provides attractive therapeutic targets for treatment. Under physiological conditions, the Met RTK, the hepatocyte growth factor/scatter factor (HGF/SF) receptor, promotes fundamental signaling cascades that modulate epithelial-to-mesenchymal transition (EMT) involved in tissue repair and embryogenesis. In cancer, increased Met activity promotes tumor growth and metastasis by providing signals for proliferation, survival, and migration/invasion. Recent clinical genomic studies have unveiled multiple mechanisms by which MET is genetically altered in GBM, including focal amplification, chromosomal rearrangements generating gene fusions, and a splicing variant mutation (exon 14 skipping, METex14del). Notably, MET overexpression contributes to chemotherapy resistance in GBM by promoting the survival of cancer stem-like cells. This is linked to distinctive Met-induced pathways, such as the upregulation of DNA repair mechanisms, which can protect tumor cells from the cytotoxic effects of chemotherapy. 
  • 124
  • 11 Mar 2024
Topic Review
Aberrant BMP2 Signaling
The most common bone disease in humans is osteoporosis (OP). Current therapeutics targeting OP have several negative side effects. Bone morphogenetic protein 2 (BMP2) is a potent growth factor that is known to activate both osteoblasts and osteoclasts. It completes these actions through both SMAD-dependent and SMAD-independent signaling. A novel interaction between the BMP type Ia receptor (BMPRIa) and casein kinase II (CK2) was discovered, and several CK2 phosphorylation sites were identified. A corresponding blocking peptide (named CK2.3) was designed to further elucidate the phosphorylation site’s function. Previously, CK2.3 demonstrated an increased osteoblast activity and decreased osteoclast activity in a variety of animal models, cell lines, and isolated human osteoblasts. It is hypothesized that CK2.3 completes these actions through the BMP signaling pathway. Furthermore, it was recently discovered that BMP2 did not elicit an osteogenic response in osteoblasts from patients diagnosed with OP, while CK2.3 did.
  • 764
  • 26 Oct 2020
Topic Review
Aberrant Phosphorylation in Cancer
Protein phosphorylation is a vital step for the coordination of cellular and molecular functions, such as the regulation of metabolism, proliferation, apoptosis, subcellular trafficking, inflammation, and other important physiological processes. Thus, altered expression of phosphoprotein will lead to deregulation of different signaling pathways as well as development and progression of cancer. Different expression patterns of various phosphoproteins have been reported in sera of various cancers and are focused.
  • 322
  • 27 Oct 2022
  • Page
  • of
  • 1814
Featured Entry Collections
>>

Featured Books

>>
Encyclopedia of Social Sciences
Encyclopedia of COVID-19
Encyclopedia of Fungi
Encyclopedia of Digital Society, Industry 5.0 and Smart City
Video Production Service
Feedback